Search results
Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Re
Guru Focus· 12 hours agoOn May 2, 2024, Shattuck Labs Inc (STTK, Financial), a trailblazer in bi-functional fusion protein technology, disclosed its financial outcomes for the first quarter ended March 31, 2024, through ...
Cullinan Oncology (NASDAQ:CGEM) Now Covered by Stifel Nicolaus
ETF DAILY NEWS· 2 days agoAnalysts at Stifel Nicolaus initiated coverage on shares of Cullinan Oncology (NASDAQ:CGEM – Get Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The brokerage set ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoReplay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy for hematological malignancies Phase 1/2 study in patients with relapsed/refractory AML
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoPomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton ...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 5 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Short Interest Update
ETF DAILY NEWS· 4 days agoActinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,980,000 ...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Morningstar· 4 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Holdings Cut by Russell Investments Group Ltd.
ETF DAILY NEWS· 3 days agoRussell Investments Group Ltd. lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 84.5% during the fourth quarter, according to its most recent Form 13F filing with ...
Syros Pharmaceuticals (NASDAQ:SYRS) Stock Price Passes Below 50 Day Moving Average of $5.94
ETF DAILY NEWS· 3 days agoSyros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.94 ...
Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $195.08
ETF DAILY NEWS· 4 days agoShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the ...